Exact Sciences (EXAS) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. JNJ
5. PLTR
6. META
7. QQQ
8. LDOS
9. HUM
10. CSCO

Go back to Exact Sciences (EXAS) Tops Q1 EPS by 3c

Exact Sciences Announces First Quarter 2022 Results

April 26, 2022 4:05 PM EDT

Total first quarter revenue of $487M, including Screening revenue of $307M, Precision Oncology revenue of $153M, and COVID-19 testing revenue of $27MTotal first quarter revenue, excluding COVID-19 testing, increased 24% compared to the first quarter of 2021, including 28% increase in Screening revenue and 18% increase in Precision Oncology revenueScreening revenue growth driven by improved sales team productivity, Cologuard rescreens, and Cologuard use in 45-49 age group

MADISON, Wis., April 26, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in... More